Literature DB >> 10605929

Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1.

G Bonizzi1, J Piette, M P Merville, V Bours.   

Abstract

The role of reactive oxygen intermediates (ROIs) in nuclear factor-kappaB (NF-kappaB) activation remains a matter of controversy. We have studied whether ROIs played any role in NF-kappaB induction by interleukin-1beta (IL-1beta) in different cell types. Our studies indicated three different pathways. IL-1beta stimulation of lymphoid cells generates ROIs, which are required for IkappaB-alpha degradation and NF-kappaB activation. The source of these ROIs is the 5-lipoxygenase (5-LOX) enzyme. In monocytic cells, ROIs are also produced in response to IL-1beta and necessary for NF-kappaB induction, but their source appears to be the NADPH oxidase complex. Finally, epithelial cells do not generate ROIs after IL-1beta stimulation, but do rapidly activate NF-kappaB. Interestingly, transfection of epithelial cells with the 5-LOX and 5-LOX activating protein expression vectors restored ROI production and ROI-dependent NF-kappaB activation in response to IL-1beta. Our data thus indicate that ROIs are cell type-specific second messengers for NF-kappaB induction by IL-1beta.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10605929     DOI: 10.1016/s0006-2952(99)00290-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  25 in total

1.  Recognition of functional roles of free radicals.

Authors:  István Bókkon
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

2.  Carbon monoxide liberated from CO-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced inflammation in the small intestine.

Authors:  Kazuhiro Katada; Aurelia Bihari; Shinjiro Mizuguchi; Norimasa Yoshida; Toshikazu Yoshikawa; Douglas D Fraser; Richard F Potter; Gediminas Cepinskas
Journal:  Inflammation       Date:  2010-04       Impact factor: 4.092

Review 3.  The applications of buckminsterfullerene C60 and derivatives in orthopaedic research.

Authors:  Qihai Liu; Quanjun Cui; Xudong Joshua Li; Li Jin
Journal:  Connect Tissue Res       Date:  2014-01-24       Impact factor: 3.417

4.  Impaired pulmonary NF-kappaB activation in response to lipopolysaccharide in NADPH oxidase-deficient mice.

Authors:  M A Koay; J W Christman; B H Segal; A Venkatakrishnan; T R Blackwell; S M Holland; T S Blackwell
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer.

Authors:  Tatiana Kisseleva; Li Song; Marina Vorontchikhina; Nikki Feirt; Jan Kitajewski; Christian Schindler
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

Review 6.  Carcinogenic metals and NF-kappaB activation.

Authors:  F Chen; M Ding; V Castranova; X Shi
Journal:  Mol Cell Biochem       Date:  2001-06       Impact factor: 3.396

7.  Microarray-based gene expression profiling in patients with cryopyrin-associated periodic syndromes defines a disease-related signature and IL-1-responsive transcripts.

Authors:  James E Balow; John G Ryan; Jae Jin Chae; Matthew G Booty; Ariel Bulua; Deborah Stone; Hong-Wei Sun; James Greene; Beverly Barham; Raphaela Goldbach-Mansky; Daniel L Kastner; Ivona Aksentijevich
Journal:  Ann Rheum Dis       Date:  2012-12-05       Impact factor: 19.103

8.  Role of nuclear factor-kappaB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells.

Authors:  María José Alcaraz; Ana María Vicente; Amparo Araico; José N Dominguez; María Carmen Terencio; María Luisa Ferrándiz
Journal:  Br J Pharmacol       Date:  2004-07-12       Impact factor: 8.739

9.  Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis.

Authors:  Yasunori Kageyama; Masaaki Takahashi; Tetsuyuki Nagafusa; Eiji Torikai; Akira Nagano
Journal:  Rheumatol Int       Date:  2007-07-28       Impact factor: 2.631

10.  Specific NFkappaB subunit activation and kinetics of cytokine induction in adenoviral keratitis.

Authors:  Jaya Rajaiya; Neda Sadeghi; James Chodosh
Journal:  Mol Vis       Date:  2009-12-25       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.